RiVOLUTiON Products for Life
RiVOLUTiON Products for Life
Vivostat® - The system at a glance
Vivostat® - The system at a glance
Vivostat® - The system at a glance
Vivostat® - The system at a glance
CRYO-S PAINLESS
Cryoanalgesia in thoracic surgery
The new year brings a lot of news that we would now like to share. The innovative CRYO-S® Painless process from the established European manufacturer Metrum Cryoflex is new to the RiVOLUTiON range. Thoracic surgery is still one of the most painful procedures for patients, during and especially after the operation. This is exactly where the CRYO-S® Painless procedure comes in: The use of cryoanalgesia, the targeted temporary freezing of intercostal nerve tracts, revolutionizes pain management in thoracic surgery. Freedom from pain, shorter hospital stays, reduction of painkillers (opiates) have a positive effect and the ERAS concept can be implemented perfectly.
Satelliten LUNCH Symposium
Frankfurter Meeting 11. Nov 2022
In the symposium, Dr. med Barbara Jacobi (Head of Adipositaszentrum Saarbrücken) presented the PSTBS study with powered staplers from Fulbright company. Furthermore, advantages, opportunities and differences in the use of different stapling technologies were shown. Powered stapling, as an evolution of mechanical staplers, is already widespread in everyday surgery. Powered Stapling impresses with 90 % less effort and 100 % stability when released, including increased compression force. Nevertheless, many surgeons prefer the proven mechanical stapler based on experience and the best surgical results. Dr. Victor Diaconu from Romania, as a top expert in the field of bariatric surgery, spoke about surgical procedures using mechanical stapling technology. He is Head of Bariatric Surgery at Provita Hospital in Bukarest/Romania and performs approximately 1,000 bariatric surgeries per year.
More about Stapling Portfollio
Meet us at DCK 2023 from April 26th to 28th at the Munich Exhibition Center. Under the umbrella topic "Innovative strategies for protection against anastomoses", a symposium with the top speakers Prof. Dr. Kai Nowak, Prof. Dr. Hans Fuchs and Dr. Felice Nappi. A cooperation between Stryker and RiVOLUTiON enables a top-class professional symposium and illuminates innovative new strategies for protecting complex anastomoses in surgery.
We look forward to your interest in the symposium and your subsequent visit to our booth F00.73 in the foyer.
The 31st Annual Meeting of the German Society for Thoracic Surgery took place in Essen from September 12th to 14th. RiVOLUTiON was represented on site by CEO Thomas Geir and Area Manager Friederike Blaschek. Three interesting days with many new contacts, discussions and the presentation of the innovative stapling portfolio of RiVOLUTiON GmbH.
On November 10th and 11th you will find us at the Frankfurt Meeting, the last congress stop this year.
The ORSY study at the RoMed Clinic in Rosenheim started in mid-September. During the initial training, RiVOLUTiON CEO Thomas Geir was able to demonstrate the application with OBSiDiAN® ASG® together with Prof. Dr. med Kai Nowak, Dr. medical Ralph Holzer and Dr. Jakob Häckl (far right in the picture) successfully. After the successful start, nothing stands in the way of the ORSY study starting at the Rosenheim Clinic with the first patients.
More about OBSiDiAN®
With September the team around Dr. Milan Ceranic from the Clinical Center Belgrade also starts with the first patients in the ORSY study. During training with RiVOLUTiON CEO Thomas Geir in Belgrade, the application with the platelet-rich biomatrix OBSiDiAN® was tried out successfully together with Dr. Ceranic and his team. We look forward to the start of the study in Belgrade and to the results of the regenerative application of OBSiDiAN®.
More about OBSiDiAN®
Recap of the training, certification & initiation of the ORSY trial at Ziekenhuis Oost-Limburg (ZOL). The ORSY study, organized by RiVOLTiON GmbH and Duomed Group, offers the possibility of subjecting the project to an independent scientific review in order to confirm the sustainable healing success in rectum surgery through the use of the fully autologously obtained OBSiDiAN®ASG® BioMatrix in a randomized controlled trial. The start of the trial inclusions is expected in the upcoming weeks.
Special thanks to Prof. Dr. Kurt Van der Speeten, Prof. Dr. Joep Knol, Marga Bogaert and Thomas Geir for this great collaboration.
More about OBSiDiAN®
OBSiDiAN® starts in Granada/Spain
The application of the bioactive OBSiDiAN®ASG® Matrix has now also started in the university hospital of Granada. Dr. Jorge Ramos Anfiel and his team performed the first interventions in colorectal surgery. RiVOLUTiON CEO Thomas Geir was supported on site by our local partner company MBA Surgical Empowerment and was now able to give the university the final approval for the official start of the ORSY study in Spain.
More about OBSiDiAN®
Live workshops organized by the RiVOLUTiON Academy are the ideal form of hands-on training for surgeons. That is why several surgeons from Germany and Austria met again in mid-July in the Kepler University Hospital in Linz, under the leadership of PRIM. UNIV.-DOZ. Dr. Andreas Shamiyeh to follow the application of the bioactive matrix OBSiDiAN ASG® live in colorectal surgery and to learn the correct application. The innovative staple line products from the extensive portfolio of RiVOLUTiON GmbH and HCP Austria were also used.
More about OBSiDiAN®
3. UMICS
Fulbright Course in Lisbon
Last week, 14 surgeons from Europe met in Lisbon for the 3rd UMICS Fulbright Course. For two days, lectures, a cadaver lab and live surgeries were all about Dr. Diego González Rivas developed method "Uniportal-VATS". The workshop days were accompanied professionally by Dr. Rivas and Prof. Javier Gallego Poveda from the Lusiadas Hospital/Lisbon. RiVOLUTiON GmbH also took part with CEO Thomas Geir and 6 surgeons from all over Germany. Thanks to Fulbright for supporting and organizing the great event.
More about Fulbright Stapling Portfolio
First clinical observations show the 100% filling of the fistula with OBSiDiAN® RFT® and promising results. For patients, this means a higher chance of a quick and complete healing of the fistula and closure of the fistula tract. Last week, the first three surgeries using the bioactive matrix OBSiDiAN® RFT® took place at the Groene Hart Hospital in the Netherlands. The complex fistula interventions were carried out on site by, Dr. Coen Baeten, Dr. Dashti Faraj and Dr. Jesse Fest with the professional support of the Dutch RiVOLUTiON sales partner Duomed. RiVOLUTiON CEO Thomas Geir was happy about the successful product launch of OBSiDiAN® RFT® for the treatment of perinatal fistulas in Gouda.
News from the RiVOLTiON Academy: Together with our Austrian sales partner HCP Austria, two OBSiDiAN® RFT® Live Workshop days took place last week. On the 1st day of the workshop, participants from Austria and Poland were on site and on the 2nd day of the workshop, participants from Austria, England, Ireland and the Emirates came to the Kepler University Hospital in Linz to look over OA Dr. Günther Klimbacher's shoulder, first theoretically and then in several live surgeries using the bioactive matrix OBSiDiAN® RFT® for complex perianal fistulas. A big "Thank you!" to Dr. Klimbacher for implementing the successful workshop.
Led by Dr. med. Tom G. Kirchner and Dr. med Björn Siemssen, the colorectal live workshop organized by the RiVOLUTiON Academy took place in Berlin on May 3rd and 4th. The workshop participants focused on the factors influencing the surgical technique and the technology used in colorectal surgery and the surgical treatment of reflux diseases. The complete portfolio of EZISURG Medical® was used successfully.
ORSY initiation meeting
in Spain
The initiation meeting for the start of the ORSY study took place in Granada, Spain, at the beginning of May. With the support of MBA, our medical technology partner on site as well our CRO, our monitoring company Raffeiner. The course was laid for a successful start of the ORSY study in Spain.
Even if Corona makes it difficult to always adhere to exact schedules, we are on course with the ORSY study. After the Kepler University Clinic Linz under the direction of Prim. Priv.-Doz. Dr. Andreas Shamiyeh and the St. John of God hospital in Graz under the direction of Prim. Prof. Dr. Felix Aigner and OA Dr. Gerald Seitinger has now also received the St. John of God hospital Vienna the green light from the ethics committee. The study will be conducted on site by Prof. Dr. Friedrich Herbst and Priv.-Doz. Dr. Bernhard Dauser and the first patients have already been introduced to the study..
Green light for the start of the RCT ORSY (OBSiDiAN in Rectal Surgery) study. The study offers the possibility to subject the project to an independent scientific assessment in order to confirm the sustainable healing success through the use of the completely autologously obtained OBSiDiAN ASG® BioMatrix in a randomized controlled study. 15 surgical departments from 7 European countries will take part. Last week the ethics committee and the CRO gave the green light for the start of studies in the Kepler University Clinic Linz under the direction of Prim. Priv.-Doz. Dr. Andreas Shamiyeh. This means that the first patients can be included in the clinical study.
Innovative into the new year... according to this motto, our partner EZISURG Medical is launching the new easyEndoTM Lite on the market. The high standard stacker in ergonomic design offers with 120° articulation option more mobility, increases surgical accuracy through improved one-handed operation while increasing efficiency. With the widest portfolio in the field of staples, RiVOLUTiON GmbH has developed into an expert for high-quality products with real added value for surgeons. Together with our manufacturers, we continue to follow the path that stands for quality, efficiency and innovation in surgery.
After 3 years of intensive work, we are proud to be able to present the first published study on the use of OBSiDiAN ASG®. Under the direction of Prim. Priv.-Doz. Dr. Andreas Shamiyeh (Kepler University Hospital Linz) and Prof. Dr. Friedrich Herbst and Priv.-Doz. Dr. Bernhard Dauser (Johannes Gott Hospital Vienna), the promising results have now been published for the first time in the renowned Surgical Technology International Journal. The study shows a significant reduction in anastomotic leakage through the use of the autologously obtained OBSiDiAN ASG® BioMatrix.
The article is listed on PubMed, where RiVOLUTiON GmbH sponsored Open Access to support the dissemination of the study results to our partners and interested specialists in our work.
.
Another successful workshop as part of the RiVOLUTiON Academy took place in mid-November at the Kepler University Hospital Linz. Under the direction of PRIM. UNIV.-DOZ. Dr. Andreas Shamiyeh 10 surgeons from all over the world met to learn more about the use and possibilities of OBSiDiAN ASG® in colorectal surgery during hands-on training. During the workshop, OA Dr. Günther Klimbacher developed the OBSiDiAN RFT® concept in the treatment of complex, perianal fistulas and demonstrate via live surgery.
Rivolution GmbH is happy to have a new international partner in the OBSiDiAN® community. With Assut Europe, a top-class professional medical technology company comes on board to take regenerative medicine a step further in Italy with OBSiDiAN®. During the joint training with CEO Thomas Geir in Rome last week, the product specialists from Assut Europe were able to familiarize themselves with the use of OBSiDiAN® in colorectal surgery and learn a lot about its enormous potential.
Under the direction of Dr. med. Tom G. Kirchner, the first colorectal live workshop with the use of EZISURG ™ staple products took place in the MIC Clinic Berlin in the middle of September. The RiVOLUTiON Academy with its live workshop and observation opportunities enables participants to learn and experience colorectal surgery at the top level, to minimize potential risk factors and to increase anastomosis security through the use of the most modern and innovative stapling technologies. Friederike Blaschek from the RiVOLUTiON team will be there on site.
The 46th annual meeting of the Berlin Society for Surgery took place in Berlin at the beginning of September under the title “Innovation in Surgery”. The establishment of innovative and regenerative medical products and procedures in surgery is the focus of RiVOLUTiON GmbH. And that's why we were very happy to be represented on site by our employee Friederike Blaschek.
The intensive work of recent years has paid off: RiVOLUTiON GmbH, together with the manufacturer Vivostat, has been awarded the contract for a Europe-wide study for OBSiDiAN. An important step that can now be made by the European economic development program "Horizon 2020 - Research and Information Framework Program" for the implementation of a Europe-wide study. 15 surgical departments from 7 European countries (AT DE, CH, IT, ESP, B, DK) as well as a center from Serbia will take part.
April 2021, OÖN
Regenerative medicine is also used in the Upper Austrian hospital of the Barmherzigen Schwerstern in Ried. Prim. Dr. Bernhard Furtmüller relies on the new process technology for intestinal operations, which aims at faster regeneration after the interventions with fewer risk factors. OBSiDiAN is being introduced in Ried as part of an Austria-wide study.
the RiVOLUTION GmbH, together with HCP Austria based in Salzburg, bundles the synergies in order to offer customers and partners even better solutions in surgery in the future. “Our companies complement each other across the board in their endeavor to introduce innovative products and sustainable processes in medical technology. Customers and patients benefit from this cooperation, '' says RiVOLUTION Managing Director Thomas Geir, who is happy to share this with him
HCP managing director Ulrich Pichler.
RiVOLUTiON managing director Thomas Geir came back from Dubai with a new partnership. The new partners AL Rowais Medical Dubai were convinced after the training with OBSiDiAN and are happy to be able to use the technology in hospitals in the future.
One of the most common risks in bowel surgery is that the staple suture does not last long after the operation and an anastomosis occurs. A solution and thus a completely new method can be found in a joint brainstorming session between Dr. med. Steffen Lancee and RiVOLUTiON emerged.